C10orf67

Across TCGA pan-cancer cohorts, C10orf67 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated C10orf67 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher C10orf67 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C10orf67 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

LUSC, LIHC, and COAD are the cancer types where C10orf67 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.140	0.762	<.001	36	view →
LIHC	OS	Median	All	0.047	0.783	<.001	12	view →
COAD	OS	Median	II,III,IV	0.001	0.860	<.001	12	view →
SKCM	DFS	Median	All	1.000	0.198	.040	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

C10orf67–LUSC (OS)

Open the LUSC breakdown →